AVBP
ArriVent BioPharma, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website arrivent.com
- Employees(FY) 42
- ISIN US04272N1028
Performance
+11.73%
1W
+19.64%
1M
-10.55%
3M
+0.5%
6M
+0.5%
YTD
+0.5%
1Y
Profile
ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.
Investment Analysis Report: AVBP
Overview:
AVBP is a pharmaceutical company operating in the Health Technology sector with a market capitalization of $718,066,082. In this report, we will conduct a comprehensive analysis of AVBP's financial health, valuation, earnings and revenue growth, profitability, operating margin, operating cash flow, and ...
Technical Analysis of AVBP 2024-05-10
Overview:
In analyzing the technical indicators for AVBP over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-16 16:05
- 2024-05-16 04:05
- 2024-05-08 08:00
- 2024-05-08 00:54
- 2024-05-07 20:00
- 2024-04-22 16:05
- 2024-04-22 04:05
- 2024-03-28 16:05
ArriVent BioPharma Reports Full Year 2023 Financial Results(GlobeNewswire)
- 2024-03-28 04:05
ArriVent BioPharma Reports Full Year 2023 Financial Results(Globenewswire)
- 2024-02-04 23:59
- 2024-01-25 08:30
Page 1 of 1
previousnext